Jaswinder Singh, MD

Board Certified – Oncology and Hematology

  • Location:BCMH Outpatient Specialty Clinics 615 W. Nursery St., Butler, MO 64730
  • Schedule an Appointment:Call 660-200-7006
  • Seeing Patients: The second Thursday afternoon of every month and the fourth Friday of every month

About Jaswinder Singh, MD

  • Medical Degree: Medical College, Chandigarh, India
  • Residency - Internal Medicine:Mount Sinai Hospital, Mount Sinai, NY
  • ResidencyUniversity of Kansas Medical Center, Kansas City, KS
  • Certifications: Hematology and OncologyBoard Certified, American Board of Internal Medicine

Dr. Jaswinder Singh is a hematologist-oncologist who also holds board certification in internal medicine.

Dr. Singh has dedicated his career to the improvement of the lives of those diagnosed with cancer. He is affiliated with the Sarah Cannon Cancer Institute at HCA Midwest Health. In 2019, he founded Mid America Cancer Care whose central mission is to provide compassionate cancer (Oncology) care to patients right in their own communities.

Since 2020, Dr. Singh has led a multi-disciplinary Tumor Board comprising primary care providers, radiologists, pathology specialists, oncology nurses and his own team of oncology providers. We are grateful to Dr. Singh for leading this group to help establish the best treatment plan for our patients.

Dr. Singh has a specific interest in complex GI (gastrointestinal) cancers. He  offers diagnostic & therapeutic oncology and hematology consultations including:

  • Oncology consults for all cancer types
  • Specializing in cancers of the liver, pancreas and GI tract
  • Hematology Consults for all blood disorders

He has been a key leader for the Liver and Pancreas Tumor Board which oversees the treatment planning for hundreds of patients annually. He also works on cutting-edge clinical trials that are leading the way in the fight against cancer.

In the years he has been a physician at Research Medical Center, he has previously served as a Medical Director for the Clinical Trials Program. Dr. Singh remains an advocate for clinical trials for the benefit of the patient and the elevation of therapies in the future.

Dr. Singh is supported by his team of oncologists and nurse practitioners, working together to help our patients through their recovery and providing quality, comprehensive cancer care.